Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation

Anne Szarewski; S Rachel Skinner; Suzanne M Garland; Barbara Romanowski; Tino F Schwarz; Dan Apter; Song-Nan Chow; Jorma Paavonen; M Rowena Del Rosario-Raymundo; Julio C Teixeira; Newton S De Carvalho; Maria Castro-Sanchez; Xavier Castellsague; Willy AJ Poppe; Philippe De Sutter; Warner Huh; Archana Chatterjee; Wiebren A Tjalma; Ronald T Ackerman; Mark Martens; Kim A Papp; Jose Bajo-Arenas; Diane M Harper; Aureli Torne; Marie-Pierre David; Frank Struyf; Matti Lehtinen; Gary Dubin

Journal article

Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation

Anne Szarewski, S Rachel Skinner, Suzanne M Garland, Barbara Romanowski, Tino F Schwarz, Dan Apter, Song-Nan Chow, Jorma Paavonen, M Rowena Del Rosario-Raymundo, Julio C Teixeira, Newton S De Carvalho, Maria Castro-Sanchez, Xavier Castellsague, Willy AJ Poppe, Philippe De Sutter, Warner Huh, Archana Chatterjee, Wiebren A Tjalma, Ronald T Ackerman, Mark Martens Show all

Journal of Infectious Diseases | OXFORD UNIV PRESS INC | Published : 2013

DOI: 10.1093/infdis/jit360

University of Melbourne Researchers

Suzanne Garland Wark Author Obstetrics and Gynaecology Royal Women's Hospital/Mercy

Grants

Awarded by GlaxoSmithKline group of companies

Funding Acknowledgements

This work (NCT00122681) was supported by the GlaxoSmithKline group of companies, which designed the study in collaboration with investigators and coordinated collection, analysis, and interpretation of data. Investigators from the PATRICIA Study Group collected data for the trial and cared for the subjects. The authors had full access to all the trial data and had final responsibility for the decision to submit for publication.